the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

View All Categories
View Conferences

Drug Discovery Market Research Reports

 

Global Information, Inc. offers market intelligence on every topic in the Drug Discovery Market, including, but not limited to latest business trend on : Drug Discovery; Target Quest; Target Validation; Lead Optimization; Pharmacology; ADMET; Pharmacogenomics; Metabonomics.

We offer market research, industry forecasts, and business analysis in the Drug Discovery Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.

 
 
Prostate Cancer Drug Discoveries: what the future holds
Table of Contents Published: 2009/11 Published by: Espicom Business Intelligence
Prostate cancer (PCA) is the second leading cause of new cancer cases in men worldwide and the sixth leading cause of cancer death in men. In the US, over two million men currently suffer with PCA and it is estimated that there were 192,311 new cases and ...

Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Table of Contents Published: 2009/10 Published by: BioSeeker Group AB
This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extensively analyses 133 identified targets of protein kinase dr ...

Pipeline Insight: Disease Modification in Rheumatoid Arthritis - New drug targets compete in crowded market
Table of Contents Published: 2009/10 Published by: Datamonitor
Drugs with new mechanisms, in particular Pfizer' s oral JAK inhibitor CP-690,550 and Chugai/Roche' s Actemra (tocilizumab), will launch for rheumatoid arthritis and should offer advantages over current therapies, but do not come without some safety signal ...

Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine
Table of Contents Published: 2009/10 Published by: Datamonitor
CRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therapies. Currently, there are 77 agents in development for ...

Orphan Drug Strategies
Table of Contents Published: 2009/10 Published by: Datamonitor
With the pharmaceutical industry reducing its focus on the primary care blockbuster model, Big Pharma is now looking towards the development and commercialization of more niche, high value, often biologic therapies, for the treatment of smaller patient po ...

GlaxoSmithKline: Pipeline, Products, Performance, Potential
Table of Contents Published: 2009/10 Published by: Espicom Business Intelligence
This report provides a full review of the company' s activities together with sales forecasts for key products to 2010. ...

The Diabetes Market Outlook To 2014: Market dynamics, competitive landscape, emerging therapies
Table of Contents Published: 2009/09 Published by: Business Insights
The global diabetes market was worth $27.3bn in 2008 and was led by insulin analogs which captured 45.0% of the market followed by glitazones that captured a share of 22.8%. US is the largest diabetes market globally with sales of $12.9b in 2008 and a mar ...

Rethinking Pharmaceutical R&D: Will New Strategies Yield a Pipeline Payoff?
Table of Contents Published: 2009/09 Published by: Decision Resources, Inc.
Can radical changes to the structures and strategies of pharmaceutical R&D operations - such as creating more entrepreneurial environments modeled upon biotech companies - increase their productivity? Many major companies are reorganizing the research bra ...

The Global Bioinformatics Market: Market size, forecasts and company profiles
Table of Contents Published: 2009/09 Published by: Business Insights
This report has covered different regional markets, products and services while evaluating them over the next five years. It provides the information about the largest regional market and factors influencing them, while defining the opportunities they hav ...

Competitive Outlook on Lung Cancer Drug Development
Table of Contents Published: 2009/08 Published by: BioSeeker Group AB
This report includes defined and up to date development strategies for 283 lung cancer therapeutic drugs (>317 projects) within the portfolio of 167 investigators, from Ceased to Marketed. In total the report assesses three different sub-indications of lu ...

Competitor Analysis: Targeted Therapy of Hepatitis C
Table of Contents Published: 2009/08 Published by: La Merie
The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2009. Purchase of the downloadable pdf re ...

Cell-Based Assays for Drug Discovery
Table of Contents Published: 2009/08 Published by: Trimark Publications
The area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-content screening (HCS) and analysis and is composed of those applications th ...

Global Drug Manufacturing Industry Outlook to 2010: Buyer Spend and Procurement Strategies and the Impact of Recession and Recovery
Table of Contents Published: 2009/07 Published by: Global Markets Direct
Global Drug Manufacturing Industry Outlook to 2010 is a new report published by Global Markets Direct in association with ICD Research that analyzes how drug manufacturing companies products & services spend, procurement strategies & practices and busines ...

Data Mining in Drug Development and Translational Medicine Overview
Table of Contents Published: 2009/07 Published by: Insight Pharma Reports
The biopharmaceutical industry is grappling not only with sheer data volume but with the ability of researchers to extract information through identification and contextual analysis of those data that are relevant to a particular set of investigations. ...

Outsourcing Preclinical Studies to China: Benefits and Challenges Overview
Table of Contents Published: 2009/07 Published by: Insight Pharma Reports
This report describes the impact that language skills and the shortages of key disciplines have on how best to structure preclinical studies in China. Also evaluated are the broad issues such as IP protection and CRO ownership as well as laboratory animal ...

Pipeline and Commercial Insight: Obesity - The $11 billion market that never was
Table of Contents Published: 2009/07 Published by: Datamonitor
The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, re ...

The Vaccines Market Outlook To 2014: Competitive landscape, pipeline analysis, growth opportunities and market forecasts
Table of Contents Published: 2009/07 Published by: Business Insights
The $11.1bn global vaccines market demonstrated flat y-o-y growth in 2008 as per IMS Health. The combination of new biotechnology research techniques and manufacturing technologies have created a new vibrant vaccine business. ...

Colorectal Cancer Drug Discoveries: what the future holds
Table of Contents Published: 2009/07 Published by: Espicom Business Intelligence
The worldwide incidence of colorectal cancer (CRC) is approximately one million cases per year and, in the US, it is the third most common cancer in both sexes, accounting for around 8.5 per cent of all cancer deaths. ...

Lymphoma Drug Development Strategies at Work - Define Your Competition
Table of Contents Published: 2009/06 Published by: BioSeeker Group AB
This report includes defined and up to date development strategies for 176 lymphoma therapeutic drugs (>230 projects) within the portfolio of 106 investigators, from Ceased to Marketed. In total the report assesses five different sub-indications of lympho ...

Opportunities in Menopausal Treatments: Will New Therapies Overtake Hormone Replacement?
Table of Contents Published: 2009/06 Published by: Decision Resources, Inc.
For decades, the effi cacy of hormone replacement therapy (HRT) for some of menopause' s most troublesome symptoms eliminated any incentive to develop new approaches to treatment. However, data questioning the safety of estrogen-containing therapies have ...

U.S. Injectable Drug Pipeline
Table of Contents Published: 2009/06 Published by: Frost & Sullivan
This research service covers the U.S. injectable drug pipeline in 2009. Included are technology trends, Phase III pipeline analysis, selected Phase II and I pipeline analysis. The market is segmented by injectable drug delivery route: subcutaneous injecta ...

The US Pharmaceutical Market Outlook To 2014: Market trends, leading players and forecasts
Table of Contents Published: 2009/06 Published by: Business Insights
The US healthcare system involves a multitude of stakeholders; a mix of public and private players. The government funds healthcare for certain sections of the society while majority of the population has a private health insurance sponsored by employers. ...

IT Software Tools for Life Science and Drug Discovery R&D
Published: 2009/06 Published by: Fuji-Keizai U.S.A., Inc.
This report presents IT Software Tools for Life Science and Drug Discovery R&D. ...

Allergy Drug Pipeline and R&D 2009
Table of Contents Published: 2009/06 Published by: Fuji-Keizai U.S.A., Inc.
This report describes current global research initiatives in the field of allergies. It focuses on the most common allergies, which affect more than 300 million persons worldwide: seasonal and perennial allergic rhinitis and food allergies. ...

The Eastern European Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
Table of Contents Published: 2009/06 Published by: Business Insights
Cardiovascular diseases and metabolic disorders are the most common groups of disease in Eastern Europe. Moreover, poor housing standards have exacerbated the spread of communicable diseases such as tuberculosis, diphtheria and cholera. In Eastern Europea ...

Accelerating Lead Generation: Emerging technologies and strategies
Table of Contents Published: 2009/06 Published by: Business Insights
The number of approvals for new drugs and biologics has fallen steadily in recent years, despite increasing R&D expenditure. Cost effective and innovative approaches to drug discovery and development have therefore become particularly important to ensure ...

Pharmacogenomics for Clinical Use and in Drug Development
Table of Contents Published: 2009/06 Published by: Trimark Publications
Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the popul ...

Merck KGaA: Pipeline, Products, Performance, Potential
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
Merck' s pharmaceutical operations are divided into the Merck Serono business and Consumer Health Care. For the former, research and marketing efforts are centred on two key therapeutic areas, namely Oncology and Neurology. ...

Epilepsy - Therapy Area Pipeline Report
Table of Contents Published: 2009/05 Published by: Life Science Analytics
Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overv ...

Approaches to Reducing Phase II Attrition
Table of Contents Published: 2009/05 Published by: Insight Pharma Reports
Phase II is the critical development stage in which most clinical attrition occurs. This report focuses on approaches to improving R&D productivity in the pharmaceutical and biotechnology industries and considers: ...

Chronic Obstructive Pulmonary Disease (COPD) Market: An Analysis
Table of Contents Published: 2009/05 Published by: Koncept Analytics
The present report analyses worldwide COPD market with prevalence of the disease in major parts of the world. It talks about United States and Australian market for the medication of COPD and mortality and death rates. Economic cost is also an important s ...

New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
Table of Contents Published: 2009/05 Published by: Datamonitor
With industry consolidation, the economic downturn, and an increasing threat from generics, pharma companies are coming under greater pressure to fill their pipelines with innovative drugs. However, despite the costs and risks involved in drug development ...

The Immune/Inflammatory Pipeline: A Strategic Review
Table of Contents Published: 2009/05 Published by: Decision Resources, Inc.
The current immune/inflammatory pipeline is over 375 drugs strong, with approximately 250 companies involved in these agents' development. Yet, despite this robust pipeline size, Decision Resources analysts do not believe that any one agent in development ...

Romania Pharmaceuticals and Healthcare Report Q2 2009
Table of Contents Published: 2009/05 Published by: Business Monitor International
Romania' s pharmaceutical market has experienced rapid growth over the past four years, a trend which looks set to continue over the next five, although at a lower level. Despite the global economic downturn having major effects on foreign exchange rate ...

Hungary Pharmaceuticals and Healthcare Report Q2 2009
Table of Contents Published: 2009/05 Published by: Business Monitor International
Hungary' s recent history of slashing pharmaceutical prices, restricting reimbursement and squeezing manufacturers has made the market an increasingly unattractive proposition for multinational pharmaceutical companies. Following consistent market growt ...

China Pharmaceuticals and Healthcare Report Q2 2009
Table of Contents Published: 2009/05 Published by: Business Monitor International
China' s pharmaceutical market is the third largest in Asia Pacific, ahead of India and behind Japan. Combined sales of prescription products and over-the-counter (OTC) medicines reached US$36.99bn in 2008 - a 25.1% increase compared to the previous yea ...

Immune/Inflammatory Disease: Early-Stage R&D Technologies and Dealmaking
Table of Contents Published: 2009/05 Published by: Decision Resources, Inc.
Today' s leading autoimmune/infl ammatory disease drugs are blockbusters, but what are the remaining unmet needs and next opportunities? Dealmaking patterns indicate that Big Pharma continues to look to small technology companies to tap opportunities to t ...

Opportunities in Predictive Drug Discovery and the Use of In-Silico Tools
Table of Contents Published: 2009/05 Published by: Frost & Sullivan
This short issue based research provides a top level picture of the applications of in-silico tools within the drug discovery market in Europe. ...

European Reference Laboratories Market
Table of Contents Published: 2009/05 Published by: Frost & Sullivan
This short issue based research provides a top level picture of reference laboratory market in Europe with a key focus on opportunities for private laboratory service providers. ...

R&D Cost Cutting: Managing cost containment and safeguarding productivity
Table of Contents Published: 2009/04 Published by: Business Insights
In recent years, drug developers have been under significant pressure to introduce new products while confronting escalating R&D costs, blockbuster patent expirations and heightened regulatory scrutiny. The current global economic climate has now intensif ...

Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success
Table of Contents Published: 2009/04 Published by: Business Insights
Declining industrial productivity has forced companies to urgently address the areas of drug development that are most likely to lead to the failure of a new compound. Innovations are required that can support the earlier termination of drugs which will b ...

Pipeline Insight: Hematological Malignancies - Companies target niche indications to facilitate market entry
Table of Contents Published: 2009/04 Published by: Datamonitor
There are 224 different pipeline products in clinical development for hematological malignancies. Twenty-three (10%) of these drugs are in late-phase studies and are forecast to achieve peak sales of $3.5 billion in 2018. Drug developers are keen to repli ...

The Cardiovascular Disease Pipeline: A Strategic Review
Table of Contents Published: 2009/04 Published by: Decision Resources, Inc.
The robust and diverse cardiovascular disease (CVD) R&D pipeline is evidence of companies' awareness that these diseases remain leading causes of death worldwide, and that the chronic nature of many CVDs offers signifi cant commercial opportunity. ...

Pharmaceutical Science Exellence: CMC Activities, Resources, and Performance
Table of Contents Published: 2009/04 Published by: Best Practices, LLC
This study provides numerous operational benchmarks around CMC facilities in terms of number/geographic locations, types of CMC activity performed, and FTEs by function and advanced degrees. ...

New Drug Futures
Table of Contents Published: 2009/04 Published by: Espicom Business Intelligence
This 450-page report evaluates, compares and contrasts the prospects for the development compounds that will revolutionise the pharmaceutical industry over the next 5 years and beyond. ...

Alzheimer's Disease: Markets, Pipeline and Opportunities 2009
Table of Contents Published: 2009/04 Published by: BioPharm Reports (Technology and Markets Ltd)
Today' s armoury of approved drugs for the treatment of Alzheimer' s Disease (AD) largely depends on just five therapeutic agents. In 2007, three of these agents represented 88% of global sales, in a market that this report estimates exceeded $6 billion i ...

European CRO Markets - A Strategic Analysis
Table of Contents Published: 2009/04 Published by: Frost & Sullivan
This segment is the executive summary of the CRO Markets in Europe. ...

Medicinal Chemistry for Drug Discovery: Significance of Recent Trends
Table of Contents Published: 2009/03 Published by: Insight Pharma Reports
A thorough analysis of recent trends in medicinal chemistry and evaluation of their significance for advancing productivity in drug discovery is presented. ...

Pipeline and Commercial Insight: Nicotine Dependence - Chantix issues overshadow vaccine potential
Table of Contents Published: 2009/03 Published by: Datamonitor
With a considerable patient population and continued government focus on lowering national smoking rates, the nicotine dependence market represents a lucrative opportunity for pharmaceutical companies. With strong uptake since launch in 2006 of Pfizer' s ...

The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery
Table of Contents Published: 2009/03 Published by: Business Insights
Biobanks collect and store human biospecimens, playing a vital role in the development of novel drugs and diagnostics. In recent years, large population-based biobanks have been established which monitor the health status of participants over time to asse ...

Drug Discovery Technology Alert
Issues / Year: 12 Published by: Technical Insights, Inc.
The Drug Discovery Technology (DDT) Alert is Technical Insights' new technology research subscription that reports and analyzes the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into ...


US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.